Metabolomic Profiling of Bipolar Disorder by 1H-NMR in Serbian Patients
Metabolites · 28.04.2023 · 13 (5) · 607
DOI: 10.3390/metabo13050607 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolites, online erschienen am 28.04.2023. Verfasst von Katarina Simić und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemistry, Technology and Metallurgy, National Institute, University of Belgrade, Studentski trg 12-16, 11000 Belgrade, Serbia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Organisation for the Prohibition of Chemical Weapons, Ministry of Education and Science of the Republic of Serbia.
Abstract (Originalsprache)
Bipolar disorder (BD) is a brain disorder that causes changes in a person’s mood, energy, and ability to function. It has a prevalence of 60 million people worldwide, and it is among the top 20 diseases with the highest global burden. The complexity of this disease, including diverse genetic, environmental, and biochemical factors, and diagnoses based on the subjective recognition of symptoms without any clinical test of biomarker identification create significant difficulties in understanding and diagnosing BD. A 1H-NMR-based metabolomic study applying chemometrics of serum samples of Serbian patients with BD (33) and healthy controls (39) was explored, providing the identification of 22 metabolites for this disease. A biomarker set including threonine, aspartate, gamma-aminobutyric acid, 2-hydroxybutyric acid, serine, and mannose was established for the first time in BD serum samples by an NMR-based metabolomics study. Six identified metabolites (3-hydroxybutyric acid, arginine, lysine, tyrosine, phenylalanine, and glycerol) are in agreement with the previously determined NMR-based sets of serum biomarkers in Brazilian and/or Chinese patient samples. The same established metabolites (lactate, alanine, valine, leucine, isoleucine, glutamine, glutamate, glucose, and choline) in three different ethnic and geographic origins (Serbia, Brazil, and China) might have a crucial role in the realization of a universal set of NMR biomarkers for BD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Chemistry, Technology and Metallurgy, National Institute, University of Belgrade, Studentski trg 12-16, 11000 Belgrade, Serbia.
- Institute of General and Physical Chemistry, Studentski trg 12-16, 11158 Belgrade, Serbia.
- University of Belgrade - Faculty of Chemistry, Studentski trg 12-16, 11000 Belgrade, Serbia.
- University of Belgrade - Faculty of Medicine, Institute of Medical Chemistry, Višegradska 26, 11000 Belgrade, Serbia.
- Special Hospital for Psychiatric Diseases "Kovin", Cara Lazara 253, 26220 Kovin, Serbia.
- Institute of Chemistry, Organic Chemistry Department, State University of Campinas, Campinas 13083-970, SP, Brazil.
ORCID-Profile: Katarina Simić, Zoran Miladinović, Nataša Avramović, Dejan Gođevac, Ljubodrag Vujisić, Ljubica Tasic
Förderung
- Organisation for the Prohibition of Chemical Weapons
- Ministry of Education and Science of the Republic of Serbia
Zitieren
APA
Simić, K., Miladinović, Z., Todorović, N., Trifunović, S., Avramović, N., Gavrilović, A., Jovanović, S., Gođevac, D., Vujisić, L., Tešević, V., Tasic, L., & Mandić, B. (2023). Metabolomic Profiling of Bipolar Disorder by 1H-NMR in Serbian Patients. Metabolites, 13(5), 607. https://doi.org/10.3390/metabo13050607
Vancouver
Simić K, Miladinović Z, Todorović N, Trifunović S, Avramović N, Gavrilović A, et al. Metabolomic Profiling of Bipolar Disorder by 1H-NMR in Serbian Patients. Metabolites. 2023;13(5):607. doi:10.3390/metabo13050607
BibTeX
@article{Simi2023,
author = {Simić, Katarina and Miladinović, Zoran and Todorović, Nina and Trifunović, Snežana and Avramović, Nataša and Gavrilović, Aleksandra and Jovanović, Silvana and Gođevac, Dejan and Vujisić, Ljubodrag and Tešević, Vele and Tasic, Ljubica and Mandić, Boris},
title = {Metabolomic Profiling of Bipolar Disorder by 1H-NMR in Serbian Patients},
journal = {Metabolites},
year = {2023},
volume = {13},
number = {5},
pages = {607},
doi = {10.3390/metabo13050607}
}
EUVIMED